- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06296381
Normative Values for Peripheral Muscle Strenght in Critical Patients and Healthy Individuals (HHD-ICU)
Analysis of Peripheral Muscle Strength Measurement Methods in Healthy Individuals and Critical Patients: A Health Technology Assessment
Study Overview
Status
Conditions
Detailed Description
For this 3-year observational study, the population will consist of adult and elderly individuals of both sexes; for the healthy sample, patients without barriers to the assessment of peripheral muscle strength will meet the inclusion criteria, specifically, areas with wounds/dressings, burns, segments with fractures, or immobilization devices, while, for the critical patient population, the sample will comprise patients who are hospitalized in the Intensive Care Unit (ICU).
In the case of assessing healthy participants, an evaluation of the musculoskeletal system will be conducted to measure muscle strength (handgrip dynamometry and peripheral hand held muscle dynamometry). Additionally, the level of physical activity (International Physical Activity Questionnaire - Short Form) will also be assessed in the . Regarding critical patients, if the participant meets the criteria, the evaluation protocol will be carried out, which includes peripheral muscle strength assessment (Medical Research Council scale, Hand Dynamometer, and the Hand-Held Dynamometer) and the patient's mobility status (Perme ICU Mobility Score).
Daily screening will take place in the ICU, with eligibility assessed during the screening process. If eligible, secondary data related to the critical condition will be extracted from the participant's medical records, including anthropometric data, sociodemographic information, neurological and cardiovascular assessments, current medications, and laboratory test results. The participant's hemodynamic and respiratory stability will be monitored using a multiparameter monitor, recording data such as blood pressure, heart rate, peripheral saturation, and respiratory rate. A cardiorespiratory and clinical safety checklist will also be completed prior to conducting tests for all patients, regardless of whether they are using mechanical ventilation. The instruments used for assessment the muscle strength are the Digital Hand Dynamometer (Saehan Corporation®, DHD-1) and the Hand Held Dynamometer (HOGGAN SCIENTIFIC LLC, microFET2).
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Shirley Campos
- Phone Number: 5581999413087
- Email: shirley.campos@ufpe.br
Study Contact Backup
- Name: Pedro Vinicius Porfirio
- Phone Number: 5581993954400
- Email: pedro.porfirio@ufpe.br
Study Locations
-
-
PE
-
Recife, PE, Brazil, 50740-600
- Recruiting
- Federal University of Pernambuco (UFPE)
-
Contact:
- Shirley Campos
- Phone Number: +5581999413087
- Email: shirley.campos@ufpe.br
-
Contact:
- Pedro Vinicius Porfirio
- Phone Number: +5581993954400
- Email: pedro.porfirio@ufpe.br
-
Sub-Investigator:
- Lucas Rafael da Silva Fraga
-
Recife, PE, Brazil, 50920-460
- Not yet recruiting
- Hospital Otávio de Freitas
-
Contact:
- Shirley L Campos
- Phone Number: +5581999413087
- Email: shirley.campos@ufpe.br
-
Recife, PE, Brazil, 51030-020
- Recruiting
- Hospital Nossa Senhora Das Gracas
-
Contact:
- Shirley L Campos
- Phone Number: +5581999413087
- Email: shirley.campos@ufpe.br
-
Contact:
- Lidier Roberta Moraes Nogueira
- Phone Number: +5581995479644
- Email: lidierroberta@outlook.com
-
Sub-Investigator:
- Jose Douglas de Souza Cordeiro
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Healthy individuals of both sexes
- Patients and volunteers aged between 18 and 90 years old (youth/adults/elderly).
- Patients admitted to the ICU.
- No recent muscle injuries of both limbs for a past 6-months.
Exclusion Criteria:
Patients and volunteers < 20 years and > 90 years
Healthy individuals
- Unable to follow command completely
- Severe osteoporosis or neuromuscular disease leading to decreased muscle strength
- Presence of opened or infectious wound
- Presence of pain in evaluating muscle groups
Patients in ICU
- Unable to follow command completely
- Acute stroke
- Hip fracture, unstable cervical spine or pathological fracture
- Recent surgery involving the upper airways, chest, abdomen, or limbs
- Presence of opened or infectious wound
- Presence of pain in evaluating muscle groups
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Patients in the ICU
The ICU sample will comprised patients of both sexes, aged between 18 and 90 years old, able to do volitional tests and without barriers to the assessment of peripheral muscle strength.
|
Healthy Participants
The healthy sample will comprised volunteers of both sexes, aged between 18 and 90 years old, able to do volitional tests and without barriers to the assessment of peripheral muscle strength.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Peripheral muscle strength measured by hand held dynamometer
Time Frame: Day 1
|
Strength of the muscles of the upper and lower limbs using a digital hand held dinamometer in healthy individuals and critical patients.
|
Day 1
|
Peripheral muscle strength measured by Medical Research Council score
Time Frame: Day 1
|
Global muscle strength using the Medical Research Council-sum score (MRC score) in healthy individuals and critical patients.
The MRC score is obtained by evaluating muscle groups in the upper and lower extremities (wrist extensors, elbow flexors, abductors of the shoulder, dorsal ankle flexors, knee extensors, and hip flexors).
For each muscle group will be assigned a score between 0 and 5, and the total score can vary between 0 (worse outcome) up to 60 points (the better outcome).
|
Day 1
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Peripheral muscle strength measured by hand grip dynamometer
Time Frame: Day 1
|
Peripheral muscle strength assessed bilaterally through digital handgrip dynamometry in healthy individuals and critical patients.
|
Day 1
|
Mobility in ICU measured by Perme Intensive Care Unit Mobility Score
Time Frame: Day 1
|
The Perme Intensive Care Unit Mobility Score comprises 15 items grouped into 7 categories: (1) mental state, (2) potential barriers to mobility, (3) strength, (4) in bed mobility, (5) transfers, (6) gait and (7) endurance.
The minimum score is 0 and the maximum is 32, where the higher the score, the better outcome.
|
Day 1
|
Level of frailty in older adults by the Multidimensional Assessment of Older People (AMPI-AB)
Time Frame: Day 1
|
The AMPI-AB is composed of 17 questions based on well-known and validated scores used to detect relevant geriatric problems, such as lack of social support, multimorbidity, polypharmacy, cognitive and sensory impairment, physical limitations, depression, falls, functional dependence, weight loss and poor oral health.
The total score can vary between 0 (the best outcome) up to 21 (the worst outcome) and classifies older adults in low, intermediate or high complexity of care.
|
Day 1
|
Level of physical activity in young adults by the International Physical Activity Questionnaire - Short Form
Time Frame: Day 1
|
The International Physical Activity Questionnaire - Short Form (IPAQ-SF) has 8 items that record the activity of four intensity levels: 1) vigorous-intensity activity such as aerobics, 2) moderate-intensity activity such as leisure cycling, 3) walking, and 4) sitting.
|
Day 1
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Shirley Campos, University of Pernambuco
- Study Director: Pedro Vinicius Porfirio, University of Pernambuco
Publications and helpful links
General Publications
- Stark T, Walker B, Phillips JK, Fejer R, Beck R. Hand-held dynamometry correlation with the gold standard isokinetic dynamometry: a systematic review. PM R. 2011 May;3(5):472-9. doi: 10.1016/j.pmrj.2010.10.025.
- Hermans G, Clerckx B, Vanhullebusch T, Segers J, Vanpee G, Robbeets C, Casaer MP, Wouters P, Gosselink R, Van Den Berghe G. Interobserver agreement of Medical Research Council sum-score and handgrip strength in the intensive care unit. Muscle Nerve. 2012 Jan;45(1):18-25. doi: 10.1002/mus.22219.
- Saraiva MD, Venys AL, Abdalla FLP, Fernandes MS, Pisoli PH, Sousa DMDRV, Bianconi BL, Henrique EA, Garcia VSS, Maia LHM, Suzuki GS, Serrano PG, Hiratsuka M, Szlejf C, Jacob-Filho W, Paschoal SMP. AMPI-AB validity and reliability: a multidimensional tool in resource-limited primary care settings. BMC Geriatr. 2020 Mar 30;20(1):124. doi: 10.1186/s12877-020-01508-9.
- Perme C, Nawa RK, Winkelman C, Masud F. A tool to assess mobility status in critically ill patients: the Perme Intensive Care Unit Mobility Score. Methodist Debakey Cardiovasc J. 2014 Jan-Mar;10(1):41-9. doi: 10.14797/mdcj-10-1-41.
- Samosawala NR, Vaishali K, Kalyana BC. Measurement of muscle strength with handheld dynamometer in Intensive Care Unit. Indian J Crit Care Med. 2016 Jan;20(1):21-6. doi: 10.4103/0972-5229.173683.
- Nunez-Cortes R, Cruz BDP, Gallardo-Gomez D, Calatayud J, Cruz-Montecinos C, Lopez-Gil JF, Lopez-Bueno R. Handgrip strength measurement protocols for all-cause and cause-specific mortality outcomes in more than 3 million participants: A systematic review and meta-regression analysis. Clin Nutr. 2022 Nov;41(11):2473-2489. doi: 10.1016/j.clnu.2022.09.006. Epub 2022 Sep 16.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 6.131.540
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intensive Care Unit
-
University of MelbourneEnrolling by invitationICU Acquired Weakness | Intensive Care Unit Syndrome | Intensive Care Unit Acquired Weakness | Post Intensive Care Unit Syndrome | Post Intensive Care SyndromeAustralia
-
Seoul National University HospitalMinistry of Food and Drug Safety, KoreaCompletedPostoperative Care | Intensive Care UnitKorea, Republic of
-
Centre Hospitalier Régional d'OrléansRecruiting
-
Nantes University HospitalRecruiting
-
First People's Hospital of ChenzhouRecruiting
-
Hospira, now a wholly owned subsidiary of PfizerCompleted
-
Mayo ClinicCompletedPalliative Care | Intensive Care Unit | HospiceUnited States
-
Hospital Israelita Albert EinsteinActive, not recruitingCritical Care | Intensive Care UnitBrazil
-
Hospices Civils de LyonCompletedPediatric Intensive Care UnitFrance, Belgium, Lebanon, Switzerland
-
Taipei Veterans General Hospital, TaiwanCompletedIntensive Care Unit PatientsTaiwan